Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Lycia Therapeutics, Inc. LYCA

Full chart Compare
Set alert

Price alert · LYCA

All alert types
30.06 USD +1.26 (+4.37%)

Nov 6, 2026, 12:36 PM EST

28.91 Day range 31.18
22.19 52-week range 36.49
YTD
+0.20%
1 year
+0.20%

Revenue & Expenses

Other Income → Expenses: $4.73MExpenses → Selling, General & Admin: $6.11MExpenses → Research & Development: $40.51MExpenses → Other Operating Expenses: $1.53MExpenses → Interest Expense: $31.00KIncome Tax Benefit → Expenses: $249.00KGross Profit → Expenses: $6.74MRevenue → Gross Profit: $6.74MNet Loss → Expenses: $36.46MOther Income$4.73MIncome Tax Benefit$249.00KGross Profit$6.74MNet Loss$36.46MExpenses$48.18MSelling, General & Admin$6.11MResearch & Development$40.51MOther Operating Expenses$1.53MInterest Expense$31.00KRevenue$6.74M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

How to read it
LYCA annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
6.74M14.94M
6.74M14.94M
6.74M14.94M
48.15M47.47M
40.51M41.07M
6.11M6.40M
-41.41M-32.53M
31.00K39.00K
-249.00K7.00K
-36.46M-26.50M
-36.46M-26.50M
-36.46M-26.50M
-36.46M-26.50M
-2.59-1.98
-2.59-1.98
-2.59-1.98
-36.68M-26.46M
-36.68M-26.46M
14.10M13.40M
14.10M13.40M